Status:
RECRUITING
Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.
Lead Sponsor:
Minia University
Conditions:
Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis
Eligibility:
All Genders
9-16 years
Phase:
NA
Brief Summary
Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis
Eligibility Criteria
Inclusion
- Permanent Molar with closed Apex and diagnosed with irreversible pulpitis
- \-
Exclusion
- medically compromised children.
- non restorable tooth
- Necrotic tooth
Key Trial Info
Start Date :
July 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07138287
Start Date
July 11 2025
End Date
September 1 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minya University Faculty of Dentistry
Minya, Egypt